2019
Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors
Tang T, Abu-Sbeih H, Luo W, Lum P, Qiao W, Bresalier R, Richards D, Wang Y. Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors. Scandinavian Journal Of Gastroenterology 2019, 54: 538-545. PMID: 31079556, DOI: 10.1080/00365521.2019.1594356.Peer-Reviewed Original ResearchConceptsImmune checkpoint inhibitorsUpper GI symptomsRisk factorsGI symptomsCheckpoint inhibitorsGI inflammationAnti-PD-1/L1Non-steroidal anti-inflammatory drugsUpper GI injuryUpper GI toxicityGastrointestinal adverse eventsUpper gastrointestinal symptomsProton pump inhibitorsLower GI tractAnti-inflammatory drugsRate of ulcerationGI injuryICI initiationDuodenal involvementEndoscopic evidenceGastrointestinal symptomsGI toxicityImmunosuppressive therapyAdverse eventsGastric involvement
2018
The Constellation of Upper Gastrointestinal Symptoms and Associated Endoscopic and Histologic Features in Patients Receiving Immune Checkpoint Inhibitors
Tang T, Abu-Sbeih H, Luo W, Samdani R, Qiao W, Bresalier R, Richards D, Wang Y. The Constellation of Upper Gastrointestinal Symptoms and Associated Endoscopic and Histologic Features in Patients Receiving Immune Checkpoint Inhibitors. The American Journal Of Gastroenterology 2018, 113: s705. DOI: 10.14309/00000434-201810001-01231.Peer-Reviewed Original ResearchImmune checkpoint inhibitorsUpper gastrointestinal symptomsCheckpoint inhibitorsGastrointestinal symptomsPatientsEndoscopicHistologicSymptoms